Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.

Kuster, Sabine; Stampf, Susanne; Gerber, Bernhard; Baettig, Veronika; Weisser, Maja; Gerull, Sabine; Medinger, Michael; Passweg, Jakob; Schanz, Urs; Garzoni, Christian; Berger, Christoph; Chalandon, Yves; Mueller, Nicolas J; van Delden, Christian; Neofytos, Dionysios; Khanna, Nina (2018). Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study. Transplant infectious disease, 20(6), e12981. Wiley 10.1111/tid.12981

[img] Text
Kuster_et_al-2018-Transplant_Infectious_Disease.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (511kB)

Contemporary, comprehensive data on epidemiology and outcomes of invasive fungal disease (IFD) including breakthrough IFD among allogeneic hematopoietic stem cell transplantation (HSCT) recipients are scarce. We included 479 allogeneic HSCT recipients with 10 invasive candidiasis (IC) and 31 probable/proven invasive mold disease (IMD) from the Swiss Transplant Cohort Study from 01.2009 to 08.2013. Overall cumulative incidence was 2.3% for IC and 8.5% for probable/proven IMI: 6% for invasive aspergillosis (IA) and 2.5% for non-AspergillusIMI. Among 41 IFD, 46% IFD were breakthrough, with an overall incidence of 4.6%, more frequently caused by other-than-Aspergillus fumigatus molds than primary IFD (47.6% (10/21) vs 13% (3/23), P = 0.04). Twelve-week mortality among patients with IC was 20% and 58.6% for probable/proven IMD (60% IA and 54.6% non-Aspergillus). Our results reveal that breakthrough IFD represent a marked burden of probable/proven IFD postallogeneic HSCT and mortality remains above 50% in patients with probable/proven IMD, underscoring the ongoing challenges to prevent and treat IFD in these patients.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Garzoni, Christian

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1398-2273

Publisher:

Wiley

Language:

English

Submitter:

Lilian Karin Smith-Wirth

Date Deposited:

02 Apr 2019 08:55

Last Modified:

05 Dec 2022 15:26

Publisher DOI:

10.1111/tid.12981

PubMed ID:

30144374

Uncontrolled Keywords:

breakthrough infections hematopoietic stem cell transplantation invasive fungal diseases invasive mold disease

BORIS DOI:

10.7892/boris.125778

URI:

https://boris.unibe.ch/id/eprint/125778

Actions (login required)

Edit item Edit item
Provide Feedback